Your browser doesn't support javascript.
loading
A new era after a long wait: Vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma.
Silvani, Antonio; Franceschi, Enrico.
Affiliation
  • Silvani A; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
  • Franceschi E; IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy.
Tumori ; 110(3): 160-161, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38166539
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Brain Neoplasms / Glioma / Isocitrate Dehydrogenase / Mutation Limits: Humans Language: En Journal: Tumori Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Brain Neoplasms / Glioma / Isocitrate Dehydrogenase / Mutation Limits: Humans Language: En Journal: Tumori Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos